Accepted for/Published in: JMIR Research Protocols
Date Submitted: Nov 20, 2023
Date Accepted: Jan 11, 2024
Supporting Life Adjustment in Lung Cancer Patients Through a Comprehensive Care Program: A Controlled Before-and-After Trial
ABSTRACT
Background:
Diagnosis of lung cancer affects an individual’s quality of life and physical and emotional functioning. Information on survivorship care tends to be introduced at the end of treatment; however, early intervention may affect post-treatment adjustment. However, to the best of our knowledge, no study has explored the effect of early information intervention on lung cancer survivors (LCS) return to their lives.
Objective:
We report the study protocol of a comprehensive care prehabilitation intervention designed to facilitate LCS’s psychological adjustment post-treatment.
Methods:
A comprehensive care program was developed based on a literature review and qualitative study of patients with lung cancer and health professionals. The Lung Cancer Comprehensive Care program consists of educational videos and follow-up visits with a family medicine physician. To prevent contamination, the historical control group will receive routine education, while the intervention group will attend routine care and intervention. Both groups completed questionnaires before surgery (T0) and at the 1-month (T1), 6-month (T2), and 1-year (T3) follow-up visits after surgery. The primary outcome is survivors’ psychological adjustment to cancer 6 months after pulmonary resection.
Results:
The historical control group (n=441) was recruited from September 8th, 2021, to April 20th, 2022, and the intervention group (n=350) was recruited from April 22nd, 2022. to October 17th, 2022. All statistical analyses will be performed upon completion of the study.
Conclusions:
This study will examine the effectiveness of an intervention that provides general and tailored informational support to LCS, ranging from before to the end of treatment. Clinical Trial: ClinicalTrials.gov, NCT05078918. Registered on October 21, 2021. https://clinicaltrials.gov/ct2/show/NCT05078918
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.